Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « common »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
committee < common < commonest  Facettes :

List of bibliographic references indexed by common

Number of relevant bibliographic references: 69.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000A50 (2020) M O Enzmann [États-Unis] ; M P Erickson [États-Unis] ; C J Grindeland [États-Unis] ; S M C. Lopez [États-Unis] ; S E Hoover [États-Unis] ; D D Leedahl [États-Unis]Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas.
000A63 (2020) John P. Knorr [États-Unis] ; Veronika Colomy [États-Unis] ; Christine M. Mauriello [États-Unis] ; Seung Ha [États-Unis]Tocilizumab in patients with severe COVID-19: A single-center observational analysis.
000B66 (2020) Firoz Anwar ; Salma Naqvi ; Fahad A. Al-Abbasi ; Nauroz Neelofar ; Vikas Kumar ; Ankit Sahoo ; Mohammad Amjad KamalTargeting COVID-19 in Parkinson's patients: Drugs repurposed.
000B75 (2020) Dinesh Kumar Rajendran [Inde] ; Varthini Rajagopal ; S. Alagumanian ; T. Santhosh Kumar [Inde] ; S P Sathiya Prabhakaran [Inde] ; Dharun Kasilingam [Inde]Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era.
000B76 (2020) Juan A. Siordia [États-Unis] ; Michael Bernaba [États-Unis] ; Kenji Yoshino [États-Unis] ; Abid Ulhaque [États-Unis] ; Sooraj Kumar [États-Unis] ; Mario Bernaba [États-Unis] ; Edward Bergin [États-Unis]Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials.
000C12 (2020) Deep Dutta [Inde] ; Meha Sharma [Inde] ; Rahul Sharma [Inde]Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome - Clearing Safety Issues and Good Clinical Practice.
000D58 (2020) Tarek Mohamed Abd El-Aziz [Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
000E40 (2020) Florian Lemaitre [France] ; Caroline Solas [France] ; Matthieu Grégoire [France] ; Laurence Lagarce [France] ; Laure Elens [Belgique] ; Elisabeth Polard [France] ; Béatrice Saint-Salvi [France] ; Agnès Sommet [France] ; Michel Tod [France] ; Chantal Barin-Le Guellec [France]Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
000E42 (2020) Stephen L. Sturley [États-Unis] ; Tamayanthi Rajakumar [Nouvelle-Zélande] ; Natalie Hammond [Nouvelle-Zélande] ; Katsumi Higaki [Japon] ; Zsuzsa Márka [États-Unis] ; Szabolcs Márka [États-Unis] ; Andrew B. Munkacsi [Nouvelle-Zélande]Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.
000E43 (2020) Deba Prasad Dhibar [Inde] ; Navneet Arora [Inde] ; Arpit Kakkar [Inde] ; Neeraj Singla [Inde] ; Ritin Mohindra [Inde] ; Vikas Suri [Inde] ; Ashish Bhalla [Inde] ; Navneet Sharma [Inde] ; Mini P. Singh [Inde] ; Ajay Prakash [Inde] ; Lakshmi Pvm [Inde] ; Bikash Medhi [Inde]Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study.
000E51 (2020) Savalan Babapoor-Farrokhran [États-Unis] ; Zachary Port [États-Unis] ; Philip C. Wiener [États-Unis] ; Aman Amanullah [États-Unis] ; Sumeet K. Mainigi [États-Unis]Polymorphic Ventricular Tachycardia with a Normal QTc Interval in a Patient with COVID-19 and Fever: Case Report.
000E96 (2020) William A. Wood [États-Unis] ; Donna S. Neuberg [États-Unis] ; J Colton Thompson [États-Unis] ; Martin S. Tallman [États-Unis] ; Mikkael A. Sekeres [États-Unis] ; Laurie H. Sehn [Canada] ; Kenneth C. Anderson [États-Unis] ; Aaron D. Goldberg [États-Unis] ; Nathan A. Pennell [États-Unis] ; Charlotte M. Niemeyer ; Emily Tucker [États-Unis] ; Kathleen Hewitt [États-Unis] ; Robert M. Plovnick [États-Unis] ; Lisa K. Hicks [Canada]Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
000F04 (2020) Norma Francenia Santos-Sánchez [Mexique] ; Raúl Salas-CoronadoOrigin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19.
000F49 (2020) Allan Giri [États-Unis] ; Ankita Das [Inde] ; Ajoy K. Sarkar [Inde] ; Ashok K. Giri [Inde]Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
000F51 (2020) Silvia Garazzino [Italie] ; Carlotta Montagnani [Italie] ; Daniele Donà [Italie] ; Antonella Meini [Italie] ; Enrico Felici [Italie] ; Gianluca Vergine [Italie] ; Stefania Bernardi [Italie] ; Roberta Giacchero [Italie] ; Andrea Lo Vecchio [Italie] ; Paola Marchisio [Italie] ; Giangiacomo Nicolini [Italie] ; Luca Pierantoni [Italie] ; Ivana Rabbone [Italie] ; Giuseppe Banderali [Italie] ; Marco Denina [Italie] ; Elisabetta Venturini [Italie] ; Andrzej Krzysztofiak [Italie] ; Raffaele Badolato [Italie] ; Sonia Bianchini [Italie] ; Luisa Galli [Italie] ; Alberto Villani [Italie] ; Guido Castelli-Gattinara [Italie]Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.
000F56 (2020) Iván J. Nú Ez-Gil [Espagne] ; Cristina Fernández-Pérez [Espagne] ; Vicente Estrada [Espagne] ; Víctor M. Becerra-Mu Oz [Espagne] ; Ibrahim El-Battrawy [Allemagne] ; Aitor Uribarri [Espagne] ; Inmaculada Fernández-Rozas [Espagne] ; Gisela Feltes [Espagne] ; María C. Viana-Llamas [Espagne] ; Daniela Trabattoni [Italie] ; Javier L Pez-País [Espagne] ; Martino Pepe [Italie] ; Rodolfo Romero [Espagne] ; Alex F. Castro-Mejía [Équateur] ; Enrico Cerrato [Italie] ; Thamar Capel Astrua [Espagne] ; Fabrizio D'Ascenzo [Italie] ; Oscar Fabregat-Andres [Espagne] ; José Moreu [Espagne] ; Federico Guerra [Italie] ; Jaime Signes-Costa [Espagne] ; Francisco Marín [Espagne] ; Danilo Buosenso [Italie] ; Alfredo Bardají [Espagne] ; Sergio Raposeiras-Roubín [Espagne] ; Javier Elola [Espagne] ; Ángel Molino [Espagne] ; Juan J. G Mez-Doblas [Espagne] ; Mohammad Abumayyaleh [Allemagne] ; Álvaro Aparisi [Espagne] ; María Molina [Espagne] ; Asunci N Guerri [Espagne] ; Ram N Arroyo-Espliguero [Espagne] ; Emilio Assanelli [Italie] ; Massimo Mapelli [Italie] ; José M. García-Acu A [Espagne] ; Gaetano Brindicci [Italie] ; Edoardo Manzone [Espagne] ; María E. Ortega-Armas [Équateur] ; Matteo Bianco [Italie] ; Chinh Pham Trung [Espagne] ; María José Nú Ez [Espagne] ; Carmen Castellanos-Lluch [Espagne] ; Elisa García-Vázquez [Espagne] ; Noemí Cabello-Clotet [Espagne] ; Karim Jamhour-Chelh [Espagne] ; María J. Tellez [Espagne] ; Antonio Fernández-Ortiz [Espagne] ; Carlos Macaya [Espagne]Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry.
000F83 (2020) Rashmi Roongta [Inde] ; Alakendu Ghosh [Inde]Managing rheumatoid arthritis during COVID-19.
000F89 (2020) Parisa Ghasemiyeh [Iran] ; Afshin Borhani-Haghighi [Iran] ; Iman Karimzadeh [Iran] ; Soliman Mohammadi-Samani [Iran] ; Afsaneh Vazin [Iran] ; Anahid Safari [Iran] ; Adnan I. Qureshi [États-Unis]Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.
001006 (2020) Feride Marim [Turquie] ; Dilek Karadogan [Turquie] ; Tugba Sismanlar Eyuboglu [Turquie] ; Nagehan Emiralioglu [Turquie] ; Canan Gunduz Gurkan [Turquie] ; Zehra Nur Toreyin [Turquie] ; Fatma Tokgoz Akyil [Turquie] ; Aycan Yuksel [Turquie] ; Huseyin Arikan [Turquie] ; Irem Serifoglu [Turquie] ; Tugba Ramasli Gursoy [Turquie] ; Abdulsamet Sandal [Turquie] ; Metin Akgun [Turquie]Lessons Learned so Far from the Pandemic: A Review on Pregnants and Neonates with COVID-19.
001061 (2020) Burak PamukçuInflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
001230 (2020) Neeraj Sinha [Oman] ; Galit Balayla [Venezuela]Hydroxychloroquine and COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "common" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "common" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    common
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021